Apollo Endosurgery develops medical devices for the diagnosis and treatment of gastrointestinal diseases. The companyâ??s device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apolloâ??s products include the X-Tackâ?¢ Endoscopic HeliX Tacking System, the OverStitchâ?¢ Endoscopic Suturing System, the OverStitch Sxâ?¢ Endoscopic Suturing System, and the ORBERA® Intragastric Balloon. Apollo Endosurgery was founded upon the initial work of the Apollo Group, an international think tank of world-renowned gastroenterologists and surgeons from five leading universities (Mayo Clinic, Johns Hopkins, Medical University of South Carolina, University of Texas Medical Branch-Galveston and Chinese University-Hong Kong.) Disappointed with the pace of innovation in therapeutic flexible endoscopy, the Group assembled in 1998 (Timeline) with the goal to advance the new discipline; their specific focus was the use of long, flexible instruments deployed through a natural orifice in order to diagnose and potentially treat gastrointestinal disorders.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
N/A
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Apollo Endosurgery Inc market cap is $475.49M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Apollo Endosurgery Inc 52 week high is $10.30 as of November 17, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Apollo Endosurgery Inc 52 week low is $3.49 as of November 17, 2026.
Apollo Endosurgery Inc stock price today is $10.00.
Apollo Endosurgery Inc stock price yesterday was $9.92.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Apollo Endosurgery Inc's P/E ratio is -10.21.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Apollo Endosurgery Inc P/B ratio is 12.8808.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Apollo Endosurgery Inc 50-day moving average is $9.92.